Review



elisa based surrogate assay cpasstm  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation elisa based surrogate assay cpasstm
    Elisa Based Surrogate Assay Cpasstm, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+based+surrogate+assay+cpasstm/elisa+based+surrogate+assay+cpasstm/pm38621337-44-14-19
    Average 90 stars, based on 1 article reviews
    elisa based surrogate assay cpasstm - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Virus:

    Article Title: Duration of antibody response to the receptor binding domain of SARS-CoV-2 in infected or vaccinated individuals - A one year retrospective cohort study.
    Article Snippet: .. The detection of total SARS-CoV-2 virus neutralizing antibodies was performed with the commercially available ELISA based surrogate assay cPassTM (GenScript) according to the manufacturer’s instructions. .. Plates were read at 450 nm on a TECAN Spark10M spectrophotometer, and percent inhibition was calculated using the formula provided by the manufacturer:

    Enzyme-linked Immunosorbent Assay:

    Article Title: Duration of antibody response to the receptor binding domain of SARS-CoV-2 in infected or vaccinated individuals - A one year retrospective cohort study.
    Article Snippet: .. The detection of total SARS-CoV-2 virus neutralizing antibodies was performed with the commercially available ELISA based surrogate assay cPassTM (GenScript) according to the manufacturer’s instructions. .. Plates were read at 450 nm on a TECAN Spark10M spectrophotometer, and percent inhibition was calculated using the formula provided by the manufacturer:

    Surrogate Assay:

    Article Title: Duration of antibody response to the receptor binding domain of SARS-CoV-2 in infected or vaccinated individuals - A one year retrospective cohort study.
    Article Snippet: .. The detection of total SARS-CoV-2 virus neutralizing antibodies was performed with the commercially available ELISA based surrogate assay cPassTM (GenScript) according to the manufacturer’s instructions. .. Plates were read at 450 nm on a TECAN Spark10M spectrophotometer, and percent inhibition was calculated using the formula provided by the manufacturer:



    Similar Products

    elisa based surrogate assay cpasstm  (GenScript corporation)
    90
    GenScript corporation elisa based surrogate assay cpasstm
    Elisa Based Surrogate Assay Cpasstm, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+based+surrogate+assay+cpasstm/elisa+based+surrogate+assay+cpasstm/pm38621337-44-14-19
    Average 90 stars, based on 1 article reviews
    elisa based surrogate assay cpasstm - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cpasstm elisa-based sars-cov-2 surrogate virus neutralization antibody detection test kit  (GenScript corporation)
    90
    GenScript corporation cpasstm elisa-based sars-cov-2 surrogate virus neutralization antibody detection test kit
    ( a ) The total anti-S antibodies (including IgG) to the <t>SARS-CoV-2</t> spike protein receptor binding domain (RBD) counts. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) Neutralizing antibodies counts. Data were measured at 3 and 5 weeks after first vaccination, and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.
    Cpasstm Elisa Based Sars Cov 2 Surrogate Virus Neutralization Antibody Detection Test Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+based+surrogate+assay+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc08539465-57-3-11
    Average 90 stars, based on 1 article reviews
    cpasstm elisa-based sars-cov-2 surrogate virus neutralization antibody detection test kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( a ) The total anti-S antibodies (including IgG) to the SARS-CoV-2 spike protein receptor binding domain (RBD) counts. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) Neutralizing antibodies counts. Data were measured at 3 and 5 weeks after first vaccination, and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.

    Journal: Vaccines

    Article Title: Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination

    doi: 10.3390/vaccines9101145

    Figure Lengend Snippet: ( a ) The total anti-S antibodies (including IgG) to the SARS-CoV-2 spike protein receptor binding domain (RBD) counts. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) Neutralizing antibodies counts. Data were measured at 3 and 5 weeks after first vaccination, and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.

    Article Snippet: The cPass™ ELISA-based SARS-CoV-2 surrogate virus neutralization antibody detection test kit (GenScript Biotech Corporation, Piscataway, NJ, USA), applies an indirect detection method via assessing antibody-mediated inhibition of SARS-CoV-2 RBD binding to the human host receptor angiotensin-converting enzyme 2.

    Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Neutralization

    ( a ) The total anti-S antibodies (including IgG) to the SARS-CoV-2 spike protein receptor-binding domain (RBD) counts by gender. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) Neutralizing antibodies counts by gender. Data were measured at 3 and 5 weeks after first vaccination, and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.

    Journal: Vaccines

    Article Title: Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination

    doi: 10.3390/vaccines9101145

    Figure Lengend Snippet: ( a ) The total anti-S antibodies (including IgG) to the SARS-CoV-2 spike protein receptor-binding domain (RBD) counts by gender. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) Neutralizing antibodies counts by gender. Data were measured at 3 and 5 weeks after first vaccination, and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.

    Article Snippet: The cPass™ ELISA-based SARS-CoV-2 surrogate virus neutralization antibody detection test kit (GenScript Biotech Corporation, Piscataway, NJ, USA), applies an indirect detection method via assessing antibody-mediated inhibition of SARS-CoV-2 RBD binding to the human host receptor angiotensin-converting enzyme 2.

    Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Neutralization

    ( a ) The total anti-S antibodies (including IgG) to the SARS-CoV-2 spike protein receptor-binding domain (RBD) counts by age. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) NeuTable 3 and 5 weeks after first vaccination and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.

    Journal: Vaccines

    Article Title: Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination

    doi: 10.3390/vaccines9101145

    Figure Lengend Snippet: ( a ) The total anti-S antibodies (including IgG) to the SARS-CoV-2 spike protein receptor-binding domain (RBD) counts by age. Data were measured at 3 and 5 weeks after first vaccination and 4 months after second vaccination. ( b ) NeuTable 3 and 5 weeks after first vaccination and 4 months after second vaccination with an ELISA-based SARS-CoV-2 Surrogate Virus Neutralization Test Kit.

    Article Snippet: The cPass™ ELISA-based SARS-CoV-2 surrogate virus neutralization antibody detection test kit (GenScript Biotech Corporation, Piscataway, NJ, USA), applies an indirect detection method via assessing antibody-mediated inhibition of SARS-CoV-2 RBD binding to the human host receptor angiotensin-converting enzyme 2.

    Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Neutralization